| Primary | Mean Change in Pain Assessed by Numerical Rating Scale (NRS) From Baseline to 3 Months | Numerical Rating Scale (NRS) is a scale which measures pain intensity from 0-10, with 0 being no pain and 10 being worst pain. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From Baseline to 3 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| | | Title | Denominators | Categories |
|---|
| | | Title | Measurements |
|---|
| - OG0002.3± 2.5
- OG0013.3± 2.7
|
|
| |
| Primary | Mean Change in Pain Assessed by Numerical Rating Scale (NRS) From Baseline to 6 Months | Numerical Rating Scale (NRS) is a scale which measures pain intensity from 0-10, with 0 being no pain and 10 being worst pain. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From Baseline to 6 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Primary | Mean Change in Pain Assessed by Numerical Rating Scale (NRS) From Baseline to 12 Months | Numerical Rating Scale (NRS) is a scale which measures pain intensity from 0-10, with 0 being no pain and 10 being worst pain. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From Baseline to 12 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Primary | Mean Change in Pain Assessed by Numerical Rating Scale (NRS) From Baseline to 18 Months | Numerical Rating Scale (NRS) is a scale which measures pain intensity from 0-10, with 0 being no pain and 10 being worst pain. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From Baseline to 18 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Primary | Mean Change in Pain Assessed by Numerical Rating Scale (NRS) From Baseline to 24 Months | Numerical Rating Scale (NRS) is a scale which measures pain intensity from 0-10, with 0 being no pain and 10 being worst pain. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From Baseline to 24 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Health Domains Assessed by PROMIS-29 Scale From Baseline to 3 Months | Patient Reported Outcomes Measurement Information System Adult Profile The PROMIS-29 is a 29-item profile instrument that covers 7 health domains (depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and social function) with 4 questions each. The final item is an 11-point pain intensity numerical rating scale (NRS). Subjects should read each item and check the one box that most closely represents their response. Each item is scored on a scale from 1-5 with total scores for each domain ranging from 4-20. Greater scores represent more of whatever concept is being measured (e.g., depression or physical function). The scoring tables have been provided in the measure manual. Raw domain scores are converted to t-scores with a mean of 50 and a standard deviation of 10. The t-scores were validated on a sample from the general population and all items must be answered to utilize the scoring tables. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 3 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems |
|
| Secondary | Mean Change in Health Domains Assessed by PROMIS-29 Scale From Baseline to 6 Months | Patient Reported Outcomes Measurement Information System Adult Profile The PROMIS-29 is a 29-item profile instrument that covers 7 health domains (depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and social function) with 4 questions each. The final item is an 11-point pain intensity numerical rating scale (NRS). Subjects should read each item and check the one box that most closely represents their response. Each item is scored on a scale from 1-5 with total scores for each domain ranging from 4-20. Greater scores represent more of whatever concept is being measured (e.g., depression or physical function). The scoring tables have been provided in the measure manual. Raw domain scores are converted to t-scores with a mean of 50 and a standard deviation of 10. The t-scores were validated on a sample from the general population and all items must be answered to utilize the scoring tables. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 6 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems |
|
| Secondary | Mean Change in Health Domains Assessed by PROMIS-29 Scale From Baseline to 12 Months | Patient Reported Outcomes Measurement Information System Adult Profile The PROMIS-29 is a 29-item profile instrument that covers 7 health domains (depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and social function) with 4 questions each. The final item is an 11-point pain intensity numerical rating scale (NRS). Subjects should read each item and check the one box that most closely represents their response. Each item is scored on a scale from 1-5 with total scores for each domain ranging from 4-20. Greater scores represent more of whatever concept is being measured (e.g., depression or physical function). The scoring tables have been provided in the measure manual. Raw domain scores are converted to t-scores with a mean of 50 and a standard deviation of 10. The t-scores were validated on a sample from the general population and all items must be answered to utilize the scoring tables. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 12 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems |
|
| Secondary | Mean Change in Health Domains Assessed by PROMIS-29 Scale From Baseline to 18 Months | Patient Reported Outcomes Measurement Information System Adult Profile The PROMIS-29 is a 29-item profile instrument that covers 7 health domains (depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and social function) with 4 questions each. The final item is an 11-point pain intensity numerical rating scale (NRS). Subjects should read each item and check the one box that most closely represents their response. Each item is scored on a scale from 1-5 with total scores for each domain ranging from 4-20. Greater scores represent more of whatever concept is being measured (e.g., depression or physical function). The scoring tables have been provided in the measure manual. Raw domain scores are converted to t-scores with a mean of 50 and a standard deviation of 10. The t-scores were validated on a sample from the general population and all items must be answered to utilize the scoring tables. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 18 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems |
|
| Secondary | Mean Change in Health Domains Assessed by PROMIS-29 Scale From Baseline to 24 Months | Patient Reported Outcomes Measurement Information System Adult Profile The PROMIS-29 is a 29-item profile instrument that covers 7 health domains (depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and social function) with 4 questions each. The final item is an 11-point pain intensity numerical rating scale (NRS). Subjects should read each item and check the one box that most closely represents their response. Each item is scored on a scale from 1-5 with total scores for each domain ranging from 4-20. Greater scores represent more of whatever concept is being measured (e.g., depression or physical function). The scoring tables have been provided in the measure manual. Raw domain scores are converted to t-scores with a mean of 50 and a standard deviation of 10. The t-scores were validated on a sample from the general population and all items must be answered to utilize the scoring tables. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 24 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems |
|
| Secondary | Mean Change in Pain Assessed by Pain Catastrophizing Scale (PCS) From Baseline to 3 Months | The PCS is a validated, 13-item scale that evaluates 3 domains of pain-related negative thoughts (rumination, magnification, and helplessness). Subjects rate how often they have the given thought from 0 "not at all" to 4 "all the time". The total score is a sum of all responses, ranging from 0-52. Each domain has a sub-scale score calculated as a sum of the constituent responses with ranges of 0-16 for rumination, 0-12 for magnification, and 0-24 for helplessness. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 3 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Pain Assessed by Pain Catastrophizing Scale (PCS) From Baseline to 6 Months | The PCS is a validated, 13-item scale that evaluates 3 domains of pain-related negative thoughts (rumination, magnification, and helplessness). Subjects rate how often they have the given thought from 0 "not at all" to 4 "all the time". The total score is a sum of all responses, ranging from 0-52. Each domain has a sub-scale score calculated as a sum of the constituent responses with ranges of 0-16 for rumination, 0-12 for magnification, and 0-24 for helplessness. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 6 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Pain Assessed by Pain Catastrophizing Scale (PCS) From Baseline to 12 Months | The PCS is a validated, 13-item scale that evaluates 3 domains of pain-related negative thoughts (rumination, magnification, and helplessness). Subjects rate how often they have the given thought from 0 "not at all" to 4 "all the time". The total score is a sum of all responses, ranging from 0-52. Each domain has a sub-scale score calculated as a sum of the constituent responses with ranges of 0-16 for rumination, 0-12 for magnification, and 0-24 for helplessness. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 12 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Pain Assessed by Pain Catastrophizing Scale (PCS) From Baseline to 18 Months | The PCS is a validated, 13-item scale that evaluates 3 domains of pain-related negative thoughts (rumination, magnification, and helplessness). Subjects rate how often they have the given thought from 0 "not at all" to 4 "all the time". The total score is a sum of all responses, ranging from 0-52. Each domain has a sub-scale score calculated as a sum of the constituent responses with ranges of 0-16 for rumination, 0-12 for magnification, and 0-24 for helplessness. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 18 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Pain Assessed by Pain Catastrophizing Scale (PCS) From Baseline to 24 Months | The PCS is a validated, 13-item scale that evaluates 3 domains of pain-related negative thoughts (rumination, magnification, and helplessness). Subjects rate how often they have the given thought from 0 "not at all" to 4 "all the time". The total score is a sum of all responses, ranging from 0-52. Each domain has a sub-scale score calculated as a sum of the constituent responses with ranges of 0-16 for rumination, 0-12 for magnification, and 0-24 for helplessness. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 24 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Attention to Pain Assessed by Pain Vigilance and Awareness Questionnaire (PVAQ) From Baseline to 3 Months | 'The PVAQ is a validated, 16-item scale that evaluates attention to pain. Subjects rate how frequently each statement represents their experience over the last 2 weeks from 0 "never" to 5 "always". Item scores are summed to produce the total score, which ranges from 0-80 with a higher score indicating greater attention to pain.' | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 3 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Attention to Pain Assessed by Pain Vigilance and Awareness Questionnaire (PVAQ) From Baseline to 6 Months | 'The PVAQ is a validated, 16-item scale that evaluates attention to pain. Subjects rate how frequently each statement represents their experience over the last 2 weeks from 0 "never" to 5 "always". Item scores are summed to produce the total score, which ranges from 0-80 with a higher score indicating greater attention to pain.' | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 6 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Attention to Pain Assessed by Pain Vigilance and Awareness Questionnaire (PVAQ) From Baseline to 12 Months | 'The PVAQ is a validated, 16-item scale that evaluates attention to pain. Subjects rate how frequently each statement represents their experience over the last 2 weeks from 0 "never" to 5 "always". Item scores are summed to produce the total score, which ranges from 0-80 with a higher score indicating greater attention to pain.' | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 12 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Attention to Pain Assessed by Pain Vigilance and Awareness Questionnaire (PVAQ) From Baseline to 18 Months | 'The PVAQ is a validated, 16-item scale that evaluates attention to pain. Subjects rate how frequently each statement represents their experience over the last 2 weeks from 0 "never" to 5 "always". Item scores are summed to produce the total score, which ranges from 0-80 with a higher score indicating greater attention to pain.' | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 18 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Mean Change in Attention to Pain Assessed by Pain Vigilance and Awareness Questionnaire (PVAQ) From Baseline to 24 Months | 'The PVAQ is a validated, 16-item scale that evaluates attention to pain. Subjects rate how frequently each statement represents their experience over the last 2 weeks from 0 "never" to 5 "always". Item scores are summed to produce the total score, which ranges from 0-80 with a higher score indicating greater attention to pain.' | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | score on a scale | | From baseline to 24 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Change in Pain Condition-related Medication Use From Baseline to 3 Months | Details will be collected regarding dosages and categories of pain-related medication. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | Morphine milligram equivalent (MME) | | From baseline to 3 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Change in Pain Condition-related Medication Use From Baseline to 6 Months | Details will be collected regarding dosages and categories of pain-related medication. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | Morphine milligram equivalent (MME) | | From baseline to 6 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Change in Pain Condition-related Medication Use From Baseline to 12 Months | Details will be collected regarding dosages and categories of pain-related medication. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | Morphine milligram equivalent (MME) | | From baseline to 12 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Change in Pain Condition-related Medication Use From Baseline to 18 Months | Details will be collected regarding dosages and categories of pain-related medication. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | Morphine milligram equivalent (MME) | | From baseline to 18 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |
| Secondary | Change in Pain Condition-related Medication Use From Baseline to 24 Months | Details will be collected regarding dosages and categories of pain-related medication. | The number of participants analyzed includes subjects who were available at that time of analysis | Posted | | Mean | Standard Deviation | Morphine milligram equivalent (MME) | | From baseline to 24 months | | | | ID | Title | Description |
|---|
| OG000 | Subjects Using BurstDR SCS Systems | Spinal cord stimulation with a Burst waveform. Burst-capable SCS system: Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means. | | OG001 | Subjects Using DRG Systems | Dorsal root ganglion stimulation. DRG Stimulator: Subjects will be implanted with a market-released Abbott DRG stimulation system. |
| |